Amarin Corp Plc (AMRN)

[Biobillionair]

What precipitated the hurried schedule? Amarin's known the timing of 80% look; plans for raising cash don't explain the schedule change. What's Pfizer been up to lately...it been really quiet...after they cancelled their PCSK9 program.

http://www.pfizer.com/news/press-release/press-release-detail/pfizer_discontinues_global_development_of_bococizumab_its_investigational_pcsk9_inhibitor

Pfizer Inc. announced today the discontinuation of the global clinical development program for bococizumab, its investigational Proprotein Convertase Subtilisin Kexin type 9 inhibitor (PCSK9i). The totality of clinical information now available for bococizumab, taken together with the evolving treatment and market landscape for lipid-lowering agents, indicates that bococizumab is not likely to provide value to patients, physicians, or shareholders. As a result, Pfizer has decided to discontinue the development program, including the two ongoing cardiovascular outcome studies.

The bold ment very little when everything still look great for PCSK9's...maybe Pfizer's looking for an Amarin value package?

Pfizer has bought back $12 Billion in stock over the past few years, perhaps it was a savings plan?

How's the hydroxy-Lipitor Vascepa patent doing Zum? NOA yet?

BB